Results 71 to 80 of about 4,735 (197)
Dutasteride is a 5alpha-reductase inhibitor in clinical use to treat endocrine conditions. The present study investigated the neuroprotective mechanisms of action of dutasteride in intact and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned ...
Morissette M +4 more
core +1 more source
Role of dutasteride in pre‐clinical ETS fusion‐positive prostate cancer models [PDF]
BACKGROUND Androgens play a crucial role in prostate cancer, hence the androgenic pathway has become an important target of therapeutic intervention.
Pienta, Kenneth J. +7 more
core +1 more source
Dutasteride is a competitive inhibitor of the enzyme 5-alpha-reductase and is commonly used to treat the symptoms of benign prostatic hyperplasia (BPH).
Romaniuk Maksym, Aksonov Pavlo
core +1 more source
ABSTRACT Background Androgenetic alopecia (AGA) is a common chronic condition significantly impacting quality of life (QoL), but few studies have explored treatment outcomes in real‐world digital health settings. Aims The objective of this study is to evaluate the effects of AGA treatment delivered through a digital healthcare platform on patient ...
Angela C. Bersch‐Ferreira +7 more
wiley +1 more source
Purpose: Finasteride and dutasteride are used to treat benign prostatic hyperplasia (BPH) and reduce the risk of developing prostate cancer. Finasteride blocks only the type 2 form of 5-alpha-reductase, whereas dutasteride blocks both type 1 and 2 forms
Dae Yul Yang +10 more
doaj +1 more source
Probing the Biological Plausibility of Fluoride as an Endocrine Disruptor
ABSTRACT Background Fluoride has come under recent scrutiny regarding concerns over potential neurodevelopmental and endocrine‐related toxicities, with recent reviews by the National Toxicology Program (NTP) and European Food Safety Authority (EFSA) concluding with moderate or reasonable confidence, respectively, that exposure to drinking water having ...
Ashley M. Mudd +2 more
wiley +1 more source
J Miller, TH TarterSouthern Illinois University School of Medicine, Department of Surgery, Springfield, IL, USAAbstract: Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary symptoms, with a prevalence of 50% by the sixth decade of ...
J Miller, TH Tarter
core
Treatment of male androgenetic alopecia with 5α-reductase inhibitors is efficacious. However, the risk of adverse sexual effects remains controversial.
Solam Lee +3 more
doaj +1 more source
Objective: To evaluate the success rates of tamsulosin and dutasteride as medical therapy based on international prostate symptom score (IPSS) in symptomatic benign prostatic hyperplasia (BPH) patients. Materials & Methods: We reviewed medical records of
Zuhirman Zamzami
doaj +1 more source
Objectives: to find the efficacy dutasteride and green tea in reducing hemorrhage on TURP patients and to evaluate the anti- angiogenesis effect. Methods: Double Blind Randomized Controlled Trial Post Test Only, with 80 samples, randomized into 4 ...
Eriawan Agung Nugroho +3 more
doaj +1 more source

